MORGAN STANLEY - LARIMAR THERAPEUTICS INC ownership

LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 67 filers reported holding LARIMAR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of LARIMAR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$96,119
-5.2%
24,334
-24.9%
0.00%
Q2 2023$101,368
-65.2%
32,386
-49.7%
0.00%
Q1 2023$291,678
-86.9%
64,388
-88.1%
0.00%
Q4 2022$2,233,657
+31.6%
540,837
+2.0%
0.00%
Q3 2022$1,697,000
+63.5%
530,293
+0.1%
0.00%
Q2 2022$1,038,000
-51.6%
529,808
-0.0%
0.00%
Q1 2022$2,146,000
+1589.8%
529,984
+4393.3%
0.00%
Q4 2021$127,000
-68.6%
11,795
-66.4%
0.00%
Q3 2021$404,000
+19.2%
35,060
+1.4%
0.00%
Q2 2021$339,000
-11.3%
34,588
+32.4%
0.00%
Q1 2021$382,000
-46.0%
26,117
-21.0%
0.00%
Q4 2020$708,000
-13.2%
33,055
-38.6%
0.00%
Q3 2020$816,000
+77.8%
53,800
+50.8%
0.00%
Q2 2020$459,00035,6880.00%
Other shareholders
LARIMAR THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CHI Advisors LLC 3,473,366$14,345,0013.82%
Opaleye Management Inc. 1,560,000$6,442,8002.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 16,941,357$69,967,8041.45%
GREAT POINT PARTNERS LLC 1,273,635$5,260,1131.03%
DAFNA Capital Management LLC 473,136$1,954,0520.55%
COMMODORE CAPITAL LP 750,000$3,0980.47%
Cheyne Capital Management (UK) LLP 63,680$262,9980.46%
Atlas Venture Advisors, Inc. 292,184$1,206,7200.42%
Perceptive Advisors 2,860,000$11,811,8000.33%
MANGROVE PARTNERS IM, LLC 1,292,812$5,339,3140.30%
View complete list of LARIMAR THERAPEUTICS INC shareholders